title: In silico characterization of immunogenic epitopes presented by HLA-Cw*0401.
abstract: BACKGROUND
  HLA-C locus products are poorly understood in part due to their low expression at the cell surface. Recent data indicate that these molecules serve as major restriction elements for human immunodeficiency virus type 1 (HIV-1) cytotoxic T lymphocyte (CTL) epitopes. We report here a structure-based technique for the prediction of peptides binding to Cw*0401. The models were rigorously trained, tested and validated using experimentally verified Cw*0401 binding and non-binding peptides obtained from biochemical studies. A new scoring scheme facilitates the identification of immunological hot spots within antigens, based on the sum of predicted binding energies of the top four binders within a window of 30 amino acids.
  
  
  RESULTS
  High predictivity is achieved when tested on the training (r(2) = 0.88, s = 3.56 kJ/mol, q(2) = 0.84, s(press) = 5.18 kJ/mol) and test (A(ROC) = 0.93) datasets. Characterization of the predicted Cw*0401 binding sequences indicate that amino acids at key anchor positions share common physico-chemical properties which correlate well with existing experimental studies.
  
  
  CONCLUSIONS
  The analysis of predicted Cw*0401-binding peptides showed that anchor residues may not be restrictive and the Cw*0401 binding pockets may possibly accommodate a wide variety of peptides with common physico-chemical properties. The potential Cw*0401-specific T-cell epitope repertoires for HIV-1 p24(gag) and gp160(gag) glycoproteins are well distributed throughout both glycoproteins, with thirteen and nine immunological hot spots for HIV-1 p24(gag) and gp160(gag) glycoproteins respectively. These findings provide new insights into HLA-C peptide selectivity, indicating that pre-selection of candidate HLA-C peptides may occur at the TAP level, prior to peptide loading in the endoplasmic reticulum.
authors: Institute for Infocomm Research, 21 Heng Mui Keng Terrace, 119613, Singapore. jctong@i2r.a-star.edu.sg
authors: Joo Chuan
authors: JC
authors: Tong
authors: Zong Hong
authors: ZH
authors: Zhang
authors: J Thomas
authors: JT
authors: August
authors: Vladimir
authors: V
authors: Brusic
authors: Tin Wee
authors: TW
authors: Tan
authors: Shoba
authors: S
authors: Ranganathan
references: Immunol Lett. 1997 Mar;55(3):145-9
references: 9161880
references: Tissue Antigens. 2000 Nov;56(5):392-404
references: 11144287
references: Eur J Immunol. 1988 May;18(5):801-10
references: 2967765
references: J Virol. 1993 Jan;67(1):438-45
references: 7677956
references: Bioinformatics. 2006 May 15;22(10):1232-8
references: 16510499
references: Immunome Res. 2006;2:1
references: 16426456
references: Immunogenetics. 1999 Nov;50(3-4):213-9
references: 10602881
references: Methods. 2004 Dec;34(4):436-43
references: 15542369
references: J Med Chem. 1999 Nov 4;42(22):4650-8
references: 10579827
references: Nucleic Acids Res. 2007 Jan;35(Database issue):D193-7
references: 17142230
references: J Exp Med. 1999 Jul 5;190(1):113-23
references: 10429675
references: J Virol. 1991 Aug;65(8):4051-6
references: 1712857
references: Eur J Immunol. 1977 Aug;7(8):580-5
references: 332508
references: Proc Natl Acad Sci U S A. 1988 Aug;85(15):5664-8
references: 2840670
references: Protein Sci. 2004 Sep;13(9):2523-32
references: 15322290
references: J Immunol. 1998 Jan 1;160(1):171-9
references: 9551969
references: J Exp Med. 1995 Jun 1;181(6):2085-95
references: 7760000
references: BMC Bioinformatics. 2006;7 Suppl 5:S7
references: 17254312
references: J Immunol. 1995 Jan 1;154(1):247-59
references: 7527812
references: J Exp Med. 1997 Apr 21;185(8):1523-8
references: 9126935
references: Bioinformatics. 2004 Aug 4;20 Suppl 1:i297-302
references: 15262812
references: Immunogenetics. 2003 Jun;55(3):172-6
references: 12750860
references: Trends Biochem Sci. 1995 Sep;20(9):374
references: 7482707
references: Immunogenetics. 2007 Jan;59(1):25-35
references: 17119951